Stock DCTH DELCATH SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Delcath Systems, Inc.

Equities

DCTH

US24661P8077

Real-time Estimate Cboe BZX
Other stock markets
 20:01:40 10/05/2024 BST 		5-day change 1st Jan Change
5.715 USD +2.79% Intraday chart for Delcath Systems, Inc. +2.70% +37.26%
05-06 Delcath Systems Says Phase 3 Data on Hepzato Kit Published in Oncology Journal MT
05-06 Delcath Systems, Inc Announces Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Delcath Systems Amends Supply, Manufacturing Agreement With Synerx Pharma, Mylan Teoranta for Melphalan Hydrochloride
MT
HC Wainwright Adjusts Delcath Systems' Price Target to $20 From $18, Maintains Buy Rating
MT
Canaccord Genuity Adjusts Delcath Systems Price Target to $21 From $18, Maintains Buy Rating
MT
Roth MKM Adjusts Price Target on Delcath Systems to $13 From $10, Maintains Buy Rating
MT
BTIG Adjusts Delcath Systems' Price Target to $20 From $19, Keeps Buy Rating
MT
HC Wainwright Adjusts Price Target on Delcath Systems to $18 From $17, Maintains Buy Rating
MT
Canaccord Genuity Adjusts Delcath Systems' Price Target to $18 From $14, Keeps Buy Rating
MT
HC Wainwright Cuts Price Target on Delcath Systems to $17 From $19, Maintains Buy Rating
MT
HC Wainwright Adjusts Delcath Systems' Price Target to $19 from $25, Keeps Buy Rating
MT
BTIG Adjusts Delcath Systems' Price Target to $20 From $23, Reiterates Buy Rating
MT
Canaccord Genuity Adjusts Delcath Systems' Price Target to $20 From $24, Reiterates Buy Rating
MT
HC Wainwright Initiates Delcath Systems at Buy Rating With $25 Price Target
MT
Delcath Says Hepzato Induces Statistically Significant Response Rates in Phase 3 Trial for Ocular Melanoma
MT
DELCATH : Roth Capital Adjusts Delcath Systems' Price Target to $25 From $20, Maintains Buy Rating
MT
DELCATH : Canaccord Genuity Initiates Coverage on Delcath Systems With Buy Rating, $24 Price Target
MT
DELCATH : BTIG Starts Delcath Systems at Buy With $23 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DCTH Stock
  4. News Delcath Systems, Inc.
  5. Analyst Reco.